![Lyn M. Dyster](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lyn M. Dyster
Private Equity Investor bij Volante Capital LLC
Profiel
Dr. Lyn M.
Dyster is a Managing Director at Volante Capital LLC.
Dr. Dyster was previously employed as a Senior Vice President-Operations by Athenex, Inc. and a Principal by Cellular Products, Inc.
She received her undergraduate degree from Washington & Jefferson College, a doctorate degree from State University of New York at Buffalo and a doctorate degree from State University of New York at Buffalo.
Actieve functies van Lyn M. Dyster
Bedrijven | Functie | Begin |
---|---|---|
Volante Capital LLC
![]() Volante Capital LLC Investment ManagersFinance Volante Capital LLC (Volante Capital) is a private equity firm founded in 2006 by Victor Lazzaro and Terry W. White. The firm is headquartered in Denver, Colorado. | Private Equity Investor | - |
Eerdere bekende functies van Lyn M. Dyster
Bedrijven | Functie | Einde |
---|---|---|
Cellular Products, Inc.
![]() Cellular Products, Inc. Medical SpecialtiesHealth Technology Cellular Products, Inc. manufactures biotechnology materials for diagnostic test kits. The private company is based in Buffalo, NY. The company was founded by Jeffrey N. Meshulam. | Corporate Officer/Principal | - |
ATHENEXPAR | Oprichter | - |
Opleiding van Lyn M. Dyster
State University of New York at Buffalo | Doctorate Degree |
Washington & Jefferson College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Athenex, Inc.
![]() Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
Cellular Products, Inc.
![]() Cellular Products, Inc. Medical SpecialtiesHealth Technology Cellular Products, Inc. manufactures biotechnology materials for diagnostic test kits. The private company is based in Buffalo, NY. The company was founded by Jeffrey N. Meshulam. | Health Technology |
Volante Capital LLC
![]() Volante Capital LLC Investment ManagersFinance Volante Capital LLC (Volante Capital) is a private equity firm founded in 2006 by Victor Lazzaro and Terry W. White. The firm is headquartered in Denver, Colorado. | Finance |